Partner news: Promethean Particles and Ceramisys work to develop nano-materials for synthetic bone graft substitutes

June 20, 2014

The University of Nottingham along with one of its spin-out businesses and MeDe partner, Promethean Particles, have secured a major EU research project with an overall value of €9.7 million. This will fund further research work alongside key industrial partners, into the large scale manufacturing of nanomaterials.
The 4-year long SHYMAN project (Sustainable Hydrothermal Manufacturing of Nanomaterials) is being co-ordinated by the University of Nottingham, while Promethean will play the leading role in terms of the manufacturing work. SHYMAN is part of the EU’s Framework Programme 7 (FP7) and enables universities and businesses across Europe to explore the potential of new technologies in industry.  In the field of medical devices the SHYMAN partner is Ceramisys – also a MeDe Innovation partner.
Promethean Particles has been working with Ceramisys, with the aim of developing nanomaterials for use in the fabrication of synthetic bone graft substitutes for dental and orthopaedic applications. The collaboration has led to optimisation of Promethean’s core technology to achieve a sustainable route to synthesise medical grade nanomaterials. The potential of these materials in the formulation and product development of advanced materials for bone repair and regeneration is being investigated at Ceramisys.
For further information contact: Sandy.Reid@proparticles.co.uk   or visit the website